Biotherapy of chronic myelogenous leukemia with interferon.
Ozer
H
H
Division of Medical Oncology, University of North Carolina, School of Medicine, Chapel Hill 27599.
D001752:Blast Crisis / Q000628:therapy; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use; D007371:Interferon-gamma / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D015465:Leukemia, Myeloid, Accelerated Phase / Q000628:therapy; D011994:Recombinant Proteins
D007370:Interferon Type I; D011994:Recombinant Proteins; D007371:Interferon-gamma; D007372:Interferons